Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 16;33(2):115-121.
doi: 10.4103/tcmj.tcmj_44_20. eCollection 2021 Apr-Jun.

Arterial stiffness: A brief review

Affiliations
Review

Arterial stiffness: A brief review

Jen-Pi Tsai et al. Tzu Chi Med J. .

Abstract

Apart from the result of multiple diseases as well as aging, arterial stiffness (AS) predicts cardiovascular disease (CVD), especially in patients with chronic kidney disease (CKD). Patients with CKD have high CVD prevalence, and an extraordinarily high risk for CVD might be related to nontraditional risk factors, including AS. The mechanism of AS development could be attributed to oxidative stress, inflammation, uremic milieu (e.g., uremic toxins), vascular calcification, and cumulative effects of traditional cardiovascular risk factors on arteries such as diabetes mellitus or hypertension. There were a variety of non-invasive techniques to measure AS. One of these techniques is carotid-femoral pulse wave velocity, which is the reference measurement of AS and is related to long-term CVD outcomes. AS progression has corresponding medical treatments with modest beneficial results. This review briefly discusses the risk factors, measurements, and treatments associated with AS.

Keywords: Arterial stiffness; Cardiovascular disease; Chronic kidney disease; Pulse wave velocity.

PubMed Disclaimer

Conflict of interest statement

Dr. Bang-Gee Hsu, the section editor at Tzu Chi Med J, had no role in the peer review process and the decision to publish this article. The other author declared that he has no conflicts of interest.

Figures

Figure 1
Figure 1
Simplified pathogenesis and outcomes of arterial stiffness (left). Models of measuring arterial stiffness (right). cfPWV: Carotid-femoral pulse wave velocity; CKD-MBD: Chronic kidney disease related mineral bone disease, CVD: Cardiovascular disease, ESRD: End-stage renal disease, ΔD/Δt: Distance divided by transit time of propagation wave between (sternal notch [N] and femoral artery [F]) and (sternal notch [N] and carotid artery [C])

References

    1. Laurent S, Boutouyrie P. Arterial stiffness: a new surrogate end point for cardiovascular disease? J Nephrol. 2007;20(Suppl 1):S45–50. - PubMed
    1. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318–27. - PubMed
    1. Ilyas B, Dhaun N, Markie D, Stansell P, Goddard J, Newby DE, et al. Renal function is associated with arterial stiffness and predicts outcome in patients with coronary artery disease. QJM. 2009;102:183–91. - PubMed
    1. Karras A, Haymann JP, Bozec E, Metzger M, Jacquot C, Maruani G, et al. Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension. 2012;60:1451–7. - PubMed
    1. Sharman JE, Davies JE, Jenkins C, Marwick TH. Augmentation index, left ventricular contractility, and wave reflection. Hypertension. 2009;54:1099–105. - PubMed